Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03497182 · ClinicalTrials.gov registry record · NA

Sepsis, Severe Sepsis and Septic Shock Detection by Breath Analysis

A NA study of Sepsis, sponsored by Landon Pediatric Foundation.

Completed
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT03497182 is a NA study of Sepsis that has completed, run by Landon Pediatric Foundation. The registered enrollment target is 45 participants, below the 6,564-participant average among 90 other Sepsis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03497182, a NA study of Sepsis, has completed, sponsored by Landon Pediatric Foundation.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

Breath samples will be collected from patients suspected of sepsis/severe sepsis or septic shock according to hospital sepsis screening criteria in the Emergency Department.

Conditions Studied

Interventions

  • DEVICE Breath sample collection

Study Locations (1)

California

  • Ventura County Medical Center - Ventura

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2017-05-02
Est. Completion 2018-10-31
Phase NA

Sponsor

Landon Pediatric Foundation

11 total trials

What the Registry Record Tells You About NCT03497182

The ClinicalTrials.gov registry entry for NCT03497182 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,564-participant average among 90 other Sepsis trials with a reported enrollment target (99% lower). The listed sponsor is Landon Pediatric Foundation, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sepsis appearing as the primary indexed condition, and to 1 intervention - of which Breath sample collection is the first listed.

NCT03497182 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03497182 about?

NCT03497182 is a clinical study titled "Sepsis, Severe Sepsis and Septic Shock Detection by Breath Analysis". Breath samples will be collected from patients suspected of sepsis/severe sepsis or septic shock according to hospital sepsis screening criteria in the Emergency Department.

What is the current status of trial NCT03497182?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2017-05-02. Estimated completion is 2018-10-31.

What conditions does trial NCT03497182 study?

This clinical trial studies the following conditions: Sepsis.

What interventions are being tested in trial NCT03497182?

The interventions under investigation include: Breath sample collection (DEVICE).

Who is sponsoring clinical trial NCT03497182?

This trial is sponsored by Landon Pediatric Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03497182 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sepsis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.